Wikipedia -WSS

Wikipedia

author：explore 2025-09-07 06:40:30 - browse：44424

Paul Berggreen, a gastroenterologist at Arizona Digestive Health who formed a new lobbying group for independent physician practices. Arizona Digestive Health/ GI Alliance

Private equity gets a bad rap in health care. But some doctors see that kind of cash and consolidation as the only way for their practices to survive — and now, they’re taking that message to Washington.

Lower pay, difficult negotiations with insurance companies, regulatory requirements from both government and commercial payers, expensive and inefficient IT systems, and the challenge of competing against hospital systems have created a “cascade of problems that seem like they are almost insurmountable” for independent practices, said Paul Berggreen, a gastroenterologist at Arizona Digestive Health.

Berggreen is joining with other doctors to start a lobbying group for private practices, the brand-new American Independent Medical Practice Association, or AIMPA, to fight against those problems and advocate for private practice physicians.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Health Care Service Corp to buy Cigna Medicare Advantage plans

leisure time

WSS

Boston competes with Raleigh

Reconstructing family trees of blood cells may help predict disease

Humana’s losses in Medicare Advantage tank its stock

Boston competes with Raleigh

How generative AI ratchets up security threats for health systems

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

explore

Wikipedia

hotspot

Activists slam private health insurers over coverage restrictions

Merck drug for rare lung condition set for approval in U.S.

The high cost of giving birth even with insurance

10 reasons why health care startups fail

In Memoriam: Notable people who died in 2023

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Hollywood unions extend contract negotiations for actors

Supreme Court mifepristone arguments center on docs' right to sue

Walensky prepares to leave CDC — and Congress — behind

Abortion pill case raises question: who can sue the FDA?

leisure time

Zyn nicotine pouches become unlikely player in latest culture war

How generative AI ratchets up security threats for health systems

FDA's naming rule on biosimilars has undermined competition

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Merck, Johnson & Johnson CEOs will testify on high drug prices

Zyn nicotine pouches become unlikely player in latest culture war

leisure time

knowledge

entertainment

leisure time